
West Pharmaceutical Services Inc
NYSE:WST

Intrinsic Value
The intrinsic value of one
WST
stock under the Base Case scenario is
190.09
USD.
Compared to the current market price of 210.85 USD,
West Pharmaceutical Services Inc
is
Overvalued by 10%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
West Pharmaceutical Services Inc
Fundamental Analysis


Revenue & Expenses Breakdown
West Pharmaceutical Services Inc
Balance Sheet Decomposition
West Pharmaceutical Services Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 404.2m |
Receivables | 569.4m |
Other Current Assets | 483.9m |
Non-Current Assets | 2.2B |
Long-Term Investments | 211.9m |
PP&E | 1.8B |
Intangibles | 117.5m |
Other Non-Current Assets | 64.2m |
Free Cash Flow Analysis
West Pharmaceutical Services Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
West Pharmaceutical Services Inc
Revenue
|
2.9B
USD
|
Cost of Revenue
|
-1.9B
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-415m
USD
|
Operating Income
|
585.2m
USD
|
Other Expenses
|
-118m
USD
|
Net Income
|
467.2m
USD
|
WST Profitability Score
Profitability Due Diligence
West Pharmaceutical Services Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Score
West Pharmaceutical Services Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
WST Solvency Score
Solvency Due Diligence
West Pharmaceutical Services Inc's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Score
West Pharmaceutical Services Inc's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
WST Price Targets Summary
West Pharmaceutical Services Inc
According to Wall Street analysts, the average 1-year price target for
WST
is 283.11 USD
with a low forecast of 247.45 USD and a high forecast of 341.25 USD.
Dividends
Current shareholder yield for WST is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
WST
stock under the Base Case scenario is
190.09
USD.
Compared to the current market price of 210.85 USD,
West Pharmaceutical Services Inc
is
Overvalued by 10%.